Pain treatment guided by your genes
Part of Cancer, Pain clinical trials.
This study looks at whether knowing your genetic makeup can help doctors choose the safest and most effective pain medicine for you before you start taking opioids. If you are being treated for cancer and may need opioid pain medication soon, this trial might be a fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently getting cancer care at the University of Chicago Medical Center.
- Your doctor thinks you will need opioid pain medication in the near future.
- You have not taken any opioid pain medication in the last 30 days.
- You do not have active leukemia or another blood cancer.
- You do not have severe kidney or liver problems.
- You are not pregnant (if you could become pregnant).
- You have not already had genetic testing for the pain-related genes being studied.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses personalized information to help understand how your current medicines interact with each other and with your genes. It may help your care team choose safer, more effective medication plans for you.
This study looks at how to put genetic testing results (pharmacogenomics) into regular doctor care. It aims to see whether using the results helps doctors choose safer, better-matched medications.
This study looks at whether using a person’s genetic information helps doctors make better decisions during planned surgery. It may help tailor care, but you would only join if you can consent and don’t have certain serious conditions.
This study looks at your genes to help doctors choose the safest and most effective cancer medicines for you. It is for children and young adults who are newly diagnosed and about to start treatment.
This study looks at how your genes affect your body's response to tramadol, a painkiller given through a pump after surgery. The goal is to see if your genetic makeup influences pain relief and side effects, which could help personalize pain treatment in the future.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
Hear when a new Adult Patients Who Are Receiving Oncologic Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.